Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.8%

11 terminated/withdrawn out of 607 trials

Success Rate

96.4%

+9.9% vs industry average

Late-Stage Pipeline

16%

95 trials in Phase 3/4

Results Transparency

6%

18 of 294 completed trials have results

Key Signals

59 recruiting18 with results7 terminated4 withdrawn

Enrollment Performance

Analytics

N/A
340(68.1%)
Phase 4
64(12.8%)
Phase 2
41(8.2%)
Phase 3
31(6.2%)
Phase 1
23(4.6%)
499Total
N/A(340)
Phase 4(64)
Phase 2(41)
Phase 3(31)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (607)

Showing 20 of 607 trials
NCT06794359Not ApplicableEnrolling By Invitation

Minimally Invasive Coronary Artery Bypass Surgery in Patients With Multi Vessel Coronary Disease

Role: lead

NCT07489456Not ApplicableRecruiting

Screening for Dysglycemia During Postpartum Period in Women With GDM

Role: lead

NCT05683106Not ApplicableCompleted

Effects of Customized Silicone Digital Orthoses in People With Diabetic Neuropathy

Role: lead

NCT05879419Phase 4Active Not Recruiting

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases

Role: lead

NCT04636255Not ApplicableCompleted

Physical Capacity in Hodgkin Lymphoma Survivors

Role: lead

NCT03711214Not ApplicableActive Not Recruiting

Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome

Role: lead

NCT07404501Not ApplicableCompleted

Gamified Approach To Burn Education

Role: lead

NCT04248894Not ApplicableCompleted

Impact of Interval Training on Sympathetic Hyperactivity and Vascular Function

Role: lead

NCT07252804Phase 4Recruiting

Immunogenicity and Safety of MenB Vaccine in Pediatric Patients With Autoimmune Rheumatic Diseases

Role: lead

NCT07087912Phase 4Recruiting

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Role: lead

NCT07275580Phase 4Not Yet Recruiting

Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases

Role: lead

NCT05685134Not ApplicableActive Not Recruiting

Epicardial Radiofrequency Catheter Ablation in Patients With Brugada Syndrome

Role: lead

NCT05907239Not ApplicableRecruiting

Effects of Focal Extracorporeal Shock Wave Therapy in the Treatment of Temporomandibular Disorders of Muscular Origin

Role: lead

NCT07242092Phase 4Not Yet Recruiting

Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs

Role: lead

NCT07486011Not ApplicableCompleted

Effects of Osteopathic Treatment in Patients With Somatosensory Tinnitus

Role: lead

NCT07351227Not ApplicableRecruiting

Pediatric Airway: Noninferiority Trial of Devices for Intubation Assessment

Role: lead

NCT07484152Phase 1Not Yet Recruiting

Motor and Non-Motor Effects of Low-Intensity Focused Ultrasound (LIFU) as a Neuromodulation Tool in Essential Tremor

Role: lead

NCT07478094Not Yet Recruiting

Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost

Role: lead

NCT07463235Phase 3Recruiting

Safety and Potency of a High Cabergoline Dosage in Microprolactinomas

Role: lead

NCT07280741Phase 4Recruiting

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Under Immunomodulators

Role: lead